Searched for
DIVIS LABORATORIES
Sunil Singhania-backed Abakkus Flexi Cap Fund increases stake in HDFC Bank, RIL and 29 others in May- Sunil Singhania-backed Abakkus Small Cap Fund adds 3 new stocks, increases stake in HDFC Bank, SBI and 49 others
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplash
- More women CXOs join India’s million-dollar pay club as domestic firms lead compensation growthNine women now earn over one million dollars annually as C-suite executives. Domestic companies are leading this rise, reflecting a focus o...01 Jun, 2026, 03.10 PM IST
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...24 May, 2026, 04.23 PM IST
- Divi's Laboratories Q4 Results: Cons PAT grows 13% YoY to Rs 751 crore, revenue up 10%; Rs 30 per share dividend announcedDivi's Laboratories Q4 Results: Divi's Laboratories announced strong financial results for the March quarter. Net profit rose 13% to Rs 751...23 May, 2026, 01.51 PM IST
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...20 May, 2026, 12.05 PM IST
- Pharma, NBFCs see fresh mutual fund buying in AprilIndian fund managers focused on defensive stocks in April. Pharmaceuticals saw increased investment due to opportunities like the semagluti...14 May, 2026, 06.26 AM IST
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...04 May, 2026, 06.00 AM IST
- Sell Divi's Laboratories, target price Rs 4,500: ICICI SecuritiesICICI Securities recommends a sell on Divi's Laboratories with a target price of Rs 4,500 despite recent quarterly growth. Management remai...05 Feb, 2025, 09.51 AM IST
- Divis Labs shares down 1.08% as Nifty fallsThe stock quoted a 52-week high price of Rs 5582.85 and low of Rs 3300.0.30 Sep, 2024, 11.16 AM IST
- Share price of Divis Labs falls as Nifty weakensA total of 2,065 shares changed hands on the counter till 01:08PM (IST).27 Sep, 2024, 01.08 PM IST
- Divis Labs shares down 1.14% as Nifty gainsThe stock quoted a 52-week high price of Rs 5582.85 and low of Rs 3300.0.26 Sep, 2024, 11.47 AM IST
- Divis Labs shares up 1.26% as Nifty dropsA total of 1,907 shares changed hands on the counter till 10:35AM (IST).25 Sep, 2024, 10.35 AM IST
- Divis Labs shares rise 0.46 per cent in Tuesday's trading sessionThe Relative Strength Index of the stock stood at 64.66 on Tuesday.24 Sep, 2024, 01.08 PM IST
- Share price of Divis Labs jumps as Sensex gains 205.36 pointsA total of 3,236 shares changed hands on the counter till 11:06AM (IST)23 Sep, 2024, 11.06 AM IST
- Divis Labs shares decline 2.21% as Sensex slidesA total of 15,796 shares changed hands on the counter till 12:27PM (IST)05 Aug, 2024, 12.28 PM IST
- Buy Divi's Laboratories, target price Rs 3742: ICICI DirectDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 98115.86 Crore) operating in Pharmace...07 Sep, 2023, 11.11 AM IST
- Buy Divi's Laboratories, target price Rs 3762: ICICI DirectDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 99034.38 Crore) operating in Pharmace...16 Aug, 2023, 10.26 AM IST
- Buy Divi's Laboratories, target price Rs 4130: Religare BrokingPromoters held 51.93 per cent stake in the company as of 30-Jun-2023, while FIIs owned 14.69 per cent, DIIs 21.03 per cent.08 Aug, 2023, 09.53 AM IST
Load More
